Kessler Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-27
| Closed | -$654 | – | 162 |
|
|
2025
Q2 | $654 | Hold |
27
| – | – | ﹤0.01% | 193 |
|
|
2025
Q1 | $684 | Hold |
27
| – | – | ﹤0.01% | 194 |
|
|
2024
Q4 | $716 | Hold |
27
| – | – | ﹤0.01% | 162 |
|
|
2024
Q3 | $781 | Hold |
27
| – | – | ﹤0.01% | 163 |
|
|
2024
Q2 | $755 | Hold |
27
| – | – | ﹤0.01% | 171 |
|
|
2024
Q1 | $749 | Buy |
+27
| New | +$749 | ﹤0.01% | 164 |
|
|
2023
Q2 | – | Sell |
-34,040
| Closed | -$1.39M | – | 184 |
|
|
2023
Q1 | $1.39M | Sell |
34,040
-322
| -0.9% | -$13.9K | 0.94% | 26 |
|
|
2022
Q4 | $1.76M | Sell |
34,362
-23,604
| -41% | -$1.13M | 1.86% | 17 |
|
|
2022
Q3 | $2.54M | Buy |
57,966
+5,932
| +11% | +$288K | 2.09% | 17 |
|
|
2022
Q2 | $2.73M | Buy |
52,034
+1,496
| +3% | +$76.2K | 2.39% | 16 |
|
|
2022
Q1 | $2.62M | Buy |
50,538
+3,631
| +8% | +$188K | 1.52% | 23 |
|
|
2021
Q4 | $2.77M | Sell |
46,907
-14,044
| -23% | -$696K | 1.56% | 20 |
|
|
2021
Q3 | $2.62M | Buy |
60,951
+29,768
| +95% | +$1.32M | 1.86% | 19 |
|
|
2021
Q2 | $1.22M | Buy |
+31,183
| New | +$1.21M | 0.97% | 32 |
|
|
2020
Q2 | – | Sell |
-113,551
| Closed | -$3.52M | – | 124 |
|
|
2020
Q1 | $3.52M | Buy |
113,551
+39,382
| +53% | +$1.34M | 4.61% | 6 |
|
|
2019
Q4 | $2.76M | Sell |
74,169
-2,598
| -3% | -$92.5K | 2.84% | 13 |
|
|
2019
Q3 | $2.62M | Buy |
76,767
+104
| +0.1% | +$3.78K | 2.92% | 16 |
|
|
2019
Q2 | $3.15M | Sell |
76,663
-5,584
| -7% | -$222K | 3.31% | 7 |
|
|
2019
Q1 | $3.31M | Sell |
82,247
-5,919
| -7% | -$237K | 3.31% | 9 |
|
|
2018
Q4 | $3.65M | Buy |
88,166
+1,914
| +2% | +$79.5K | 4.72% | 7 |
|
|
2018
Q3 | $3.61M | Buy |
86,252
+85,726
| +16,298% | +$3.3M | 3.7% | 6 |
|
|
2018
Q2 | $18K | Buy |
526
+157
| +43% | +$5.37K | 0.02% | 111 |
|
|
2018
Q1 | $12K | Hold |
369
| – | – | 0.02% | 86 |
|
|
2017
Q4 | $13K | Hold |
369
| – | – | 0.02% | 79 |
|
|
2017
Q3 | $12K | Buy |
+369
| New | +$11.9K | 0.02% | 77 |
|
|
2015
Q3 | – | Sell |
-199
| Closed | -$6K | – | 115 |
|
|
2015
Q2 | $6K | Hold |
199
| – | – | 0.01% | 90 |
|
|
2015
Q1 | $7K | Hold |
199
| – | – | 0.01% | 83 |
|
|
2014
Q4 | $6K | Buy |
+199
| New | +$5.71K | 0.01% | 102 |
|
Other funds holding PFE
Kessler Investment Group's PFE Position: Q3 2025 in Review
Kessler Investment Group sold out of Pfizer (PFE) in Q3 2025, closing a stake of 27 shares — an estimated $654 sold.
Kessler Investment Group first reported a position in PFE in Q4 2014 and held it in 28 quarters. The position peaked at $3.65M in Q4 2018. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Kessler Investment Group reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Kessler Investment Group sold 27 Pfizer shares in Q3 2025, an estimated $654.
- Kessler Investment Group first reported a position in Pfizer in Q4 2014 and held it in 28 quarters.
- Kessler Investment Group's Pfizer position peaked at $3.65M in Q4 2018.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Kessler Investment Group's 13F filing for Q3 2025, filed 9 Oct 2025.